|
Resolution: standard / high Figure 8.
Ankylosing spondylitis: rapid clinical response. Infliximab rapidly improves ASAS40 compared with placebo (n = 279 patients). P <0.001 from 2 weeks onwards. ASAS, Assessment of SpondyloArthritis International
Society. Modified with permission from [75].
Smolen and Emery Arthritis Research & Therapy 2011 13(Suppl 1):S2 doi:10.1186/1478-6354-13-S1-S2 |
